Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

Tata India Pharma & Healthcare Fund · Direct ✕HDFC Business Cycle Fund · Direct ✕

Growth of ₹10,000

Basics

Tata India Pharma & Healthcare FundHDFC Business Cycle Fund
CategorySectoral / ThematicSectoral / Thematic
PlanDirectDirect
Fund houseTataHDFC
NAV₹40.2296₹16.4070
NAV date20 Nov 202620 Nov 2026
History10.9 years4.0 years
Expense ratio1.1%1.1%
Stars★★★★★★★★★★
Growth Score67.5050.50

Returns

Tata India Pharma & Healthcare FundHDFC Business Cycle Fund
1 month+9.87%+7.69%
3 months+1.12%+1.91%
6 months+7.63%+11.83%
YTD+13.73%+7.72%
1 year+11.82%+5.98%
3 years (CAGR)+18.74%+12.01%
5 years (CAGR)+16.00%—
10 years (CAGR)+15.95%—
Since launch+13.58%+13.24%

Risk

Tata India Pharma & Healthcare FundHDFC Business Cycle Fund
Volatility15.7%15.5%
Downside volatility10.0%10.3%
Sharpe0.780.36
Sortino1.230.53
Calmar1.120.67
Return / risk1.190.78
Deepest fall−19.84%−18.04%
Days to recover375133
Below its high+0.00%+0.00%

Against benchmark

Tata India Pharma & Healthcare FundHDFC Business Cycle Fund
Alpha−2.76%+0.41%
Beta1.000.92
R²90.2%90.6%
Up capture91.7%95.3%
Down capture101.4%92.0%
Tracking error4.9%4.9%
Information ratio−0.57−0.01
Treynor0.110.05

Consistency

Tata India Pharma & Healthcare FundHDFC Business Cycle Fund
Best 1-year+76.35%+39.99%
Middle 1-year+8.85%+6.68%
Worst 1-year−17.32%−6.17%
1-year periods with a loss29.0%9.1%
Middle 3-year+21.13%+12.75%
Positive months63.9%61.1%
Best day+3.34%+4.12%
Worst day−3.09%−6.25%
Worst 5% day−1.35%−1.52%
Positive days55.4%54.9%
NAVs a year247247

SIP of ₹10,000 a month

Tata India Pharma & Healthcare FundHDFC Business Cycle Fund
5-year XIRR+18.07%—
5-year value₹9,50,065—
3-year XIRR+13.31%+8.57%
1-year XIRR+18.41%+15.07%

Holdings overlap i

Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.

Search Growth